Study Using the SpinalStim Device Following Lumbar Fusion Surgery

About this trial

Last updated 4 years ago

Study ID

CP-1702SSPM

Status

Completed

Type

Observational

Placebo

Accepting

18+ Years

All Sexes

Trial Timing

Ended 5 years ago

What is this trial about?

This study examines the effect of adjunctive use of the SpinalStim bone growth stimulator on lumbar fusion rate in high risk subjects who have had lumbar fusion surgery. All participants will wear the bone growth stimulator for a minimum of 2 hours/day for 6 months.

What are the participation requirements?

Inclusion Criteria

1. Male or female, ≥ 18 years of age at the time of Informed Consent

2. Requires a lumbar fusion surgery within 30 days of signing Informed Consent. a. Surgical approach is according to physician's discretion.

3. Subject has one or more risk factors:

* Is currently using nicotine

* multi-level lumbar fusion surgery planned

* Prior failed fusion at any lumbar level

* Subject reported diabetes

* Subject reported osteoporosis

4. Body mass index ≤ 45 kg/m2 at the time of consent.

5. Must have reliable access to an iPhone or an iPad with Wi-Fi access for downloading the free device-specific app (iPhone 5S or higher, iPad, iPad Pro, iPad mini or iTouch using iOS v9.3 or later). When the android version of the mobile app for the SpinalStim becomes available (estimated to be Dec. 2017), subjects who have reliable access to devices using android operating systems will be eligible for study inclusion.

6. Able and willing to complete electronic questionnaires and able to read and understand study instructions in English

7. Able and willing to comply with the study plan and able to understand and sign the study-specific ICF.

Exclusion Criteria

1. Scoliosis greater than 30 degrees

2. Current alcoholism or drug abuse, and/or any known current addiction to pain medications or medical marijuana

3. Any active malignancy or prior history of malignancy within last 5 years prior to fusion (except basal cell carcinoma of the skin).

4. Any clinically significant finding that places the subject at health risk, impacts the study, or affects completion of the study, in the opinion of the Investigator

5. Any psychiatric illness that prevents subject from completing the assessments accurately, in the opinion of the Investigator

6. Prisoners.